Finding 1224298 (2025-003)

Material Weakness Repeat Finding
Requirement
C
Questioned Costs
-
Year
2025
Accepted
2026-07-21
Audit: 407580
Organization: HEALTHX PARTNERS INCORPORATED (DC)
Auditor: BDO

AI Summary

  • Core Issue: HealthXP did not keep federal funds in interest-bearing accounts as required by compliance regulations.
  • Impacted Requirements: This violates §200.305(b)(11) of the Uniform Guidance, which mandates interest-bearing accounts for federal advance payments.
  • Recommended Follow-Up: Management should update cash management policies to align with federal requirements and ensure compliance moving forward.

Finding Text

Internal Control over Compliance and Compliance with Cash Management Requirements Identification of the Major Federal Program: U.S. Department of Health and Human Services Assistance Listing Number: 93.067 Assistance Listing Name: Global AIDS Grant Award Numbers under the Uniform Guidance Requirements: See Schedule of Findings and Questioned Costs for table. Criteria or Specific Requirement: In accordance with §200.305(b)(11), Federal Payment, the recipient or subrecipient must maintain advance payments of Federal funds in interest-bearing accounts unless one of the following applies: (i) the recipient or subrecipient receives less than $250,000 in Federal funding per year; (ii) The best available interest-bearing account would not reasonably be expected to earn interest in excess of $500 per year on Federal cash balances; (iii) The depository would require an average or minimum balance so high that it would not be feasible with the expected Federal and non-Federal cash resources; (iv) A foreign government or banking system prohibits or precludes interest-bearing accounts; or (v) An interest-bearing account is not readily accessible (for example, due to public or political unrest in a foreign country). Condition: During our testing of compliance, we noted that EGPAF, a HealthXP subsidiary, failed to maintain the advance payments of Federal funds under the awards NU2GGH002211, NU2GGH002301, NU2GGH002315, NU2GGH002369, NU2GGH002421, NU2GGH002425, and NU2GGH002551 in an interest-bearing account, which is noncompliant with §200.305(b)(11). Questioned Costs: There are no known or likely questioned costs. Context: This is a condition based on testing HealthXP’s compliance with specified cash management compliance requirements. The prevalence of these findings is detailed in the condition section above. The samples were selected using a non-statistical method. Cause: HealthXP’s management team failed to consistently maintain advance payments received from the funding agencies in an interest-bearing account as required. Effect: Failure to perform cash management procedures in accordance with HealthXP’s documented policies and relevant compliance requirements could result in non-compliance with federal statutes and contractual agreements. Repeat Finding: This is not a repeat finding. Recommendation: We recommend management ensure that cash management policies and procedures align with U.S. Government funding requirements. Views of Responsible Officials: HealthXP management agrees with the findings and recommendations set forth within and will refine its cash management policies and procedures. Refer to management’s corrective action plan for additional information.

Corrective Action Plan

Internal Control over Compliance and Compliance with Cash Management Requirements Contact: Aida Awaj Title: Assistant Controller Phone Number: 202-785-0072 Estimated Completion Date: August 31, 2026 Corrective Action Transition to interest-bearing accounts and move advance Federal balances into interest-bearing accounts. Also, establish a process to track interest earned on Federal advances and remit annually any interest above the $500 de minimis threshold to the federal agency per §200.305(b)(11), retaining records of calculation and remittance.

Categories

Cash Management Subrecipient Monitoring Matching / Level of Effort / Earmarking

Other Findings in this Audit

  • 1224236 2025-001
    Material Weakness Repeat
  • 1224237 2025-001
    Material Weakness Repeat
  • 1224238 2025-001
    Material Weakness Repeat
  • 1224239 2025-001
    Material Weakness Repeat
  • 1224240 2025-001
    Material Weakness Repeat
  • 1224241 2025-001
    Material Weakness Repeat
  • 1224242 2025-001
    Material Weakness Repeat
  • 1224243 2025-001
    Material Weakness Repeat
  • 1224244 2025-001
    Material Weakness Repeat
  • 1224245 2025-001
    Material Weakness Repeat
  • 1224246 2025-005
    Material Weakness Repeat
  • 1224247 2025-001
    Material Weakness Repeat
  • 1224248 2025-001
    Material Weakness Repeat
  • 1224249 2025-001
    Material Weakness Repeat
  • 1224250 2025-001
    Material Weakness Repeat
  • 1224251 2025-001
    Material Weakness Repeat
  • 1224252 2025-001
    Material Weakness Repeat
  • 1224253 2025-001
    Material Weakness Repeat
  • 1224254 2025-001
    Material Weakness Repeat
  • 1224255 2025-001
    Material Weakness Repeat
  • 1224256 2025-001
    Material Weakness Repeat
  • 1224257 2025-001
    Material Weakness Repeat
  • 1224258 2025-001
    Material Weakness Repeat
  • 1224259 2025-001
    Material Weakness Repeat
  • 1224260 2025-001
    Material Weakness Repeat
  • 1224261 2025-001
    Material Weakness Repeat
  • 1224262 2025-001
    Material Weakness Repeat
  • 1224263 2025-001
    Material Weakness Repeat
  • 1224264 2025-001
    Material Weakness Repeat
  • 1224265 2025-001
    Material Weakness Repeat
  • 1224266 2025-001
    Material Weakness Repeat
  • 1224267 2025-001
    Material Weakness Repeat
  • 1224268 2025-001
    Material Weakness Repeat
  • 1224269 2025-001
    Material Weakness Repeat
  • 1224270 2025-001
    Material Weakness Repeat
  • 1224271 2025-001
    Material Weakness Repeat
  • 1224272 2025-001
    Material Weakness Repeat
  • 1224273 2025-004
    Material Weakness Repeat
  • 1224274 2025-001
    Material Weakness Repeat
  • 1224275 2025-001
    Material Weakness Repeat
  • 1224276 2025-001
    Material Weakness Repeat
  • 1224277 2025-001
    Material Weakness Repeat
  • 1224278 2025-001
    Material Weakness Repeat
  • 1224279 2025-001
    Material Weakness Repeat
  • 1224280 2025-001
    Material Weakness Repeat
  • 1224281 2025-001
    Material Weakness Repeat
  • 1224282 2025-001
    Material Weakness Repeat
  • 1224283 2025-001
    Material Weakness Repeat
  • 1224284 2025-001
    Material Weakness Repeat
  • 1224285 2025-001
    Material Weakness Repeat
  • 1224286 2025-001
    Material Weakness Repeat
  • 1224287 2025-001
    Material Weakness Repeat
  • 1224288 2025-001
    Material Weakness Repeat
  • 1224289 2025-004
    Material Weakness Repeat
  • 1224290 2025-005
    Material Weakness Repeat
  • 1224291 2025-003
    Material Weakness Repeat
  • 1224292 2025-002
    Material Weakness Repeat
  • 1224293 2025-003
    Material Weakness Repeat
  • 1224294 2025-003
    Material Weakness Repeat
  • 1224295 2025-003
    Material Weakness Repeat
  • 1224296 2025-003
    Material Weakness Repeat
  • 1224297 2025-003
    Material Weakness Repeat
  • 1224299 2025-005
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
98.U00 USAID/Tanzania's Client-Centered Health Program - HIV and Tuberculosis Northern (C3HP-NIV&TB Northern) $15.41M
98.U00 Global Health Supply Chain (GSHC) - Procurement and Supply Management (PSM) $3.18M
12.350 DEPARTMENT OF DEFENSE HIV/AIDS PREVENTION PROGRAM $2.64M
98.U00 Donated Commodities $2.17M
98.U00 Southern Africa's Attain & Sustain 95-95-95, Present New Infections and Reach All Populations for Epidemic Control (ASPIRE) $1.03M
93.067 GLOBAL AIDS $1.01M
98.001 USAID FOREIGN ASSISTANCE FOR PROGRAMS OVERSEAS $894,682
12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT $203,175
98.U00 PMI Prevention of Malaria Through Vector Control $190,245
98.U00 USAID Western Kenya Sanitation (WKSP) $146,407
98.U00 Ethiopia Urban Water, Sanitation and Hygiene (WASH) Activity $123,146
98.U00 USAID West Africa Municipal Wash (MuniWASH) $66,273
98.U00 USAID WASH Services $60,267
98.U00 WCA_USAID_Transform IDIQ $1,285